Salvage Therapy with 177Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Salvage Therapy with 177Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors

Published:2010-02-11 Issue:3 Volume:51 Page:383-390
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

van Essen Martijn,Krenning Eric P.,Kam Boen L.R.,de Herder Wouter W.,Feelders Richard A.,Kwekkeboom Dik J.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference14 articles.

1. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2. Gastroenteropancreatic Endocrine Tumours: Effect of Sandostatin® on Tumour Growth

3. Long-Term Management of the Carcinoid Syndrome Treatment with octreotide alone and in combination with alpha-interferon

4. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors

5. Chemotherapy for Gastro-Enteropancreatic Endocrine Tumours

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias;Current Issues in Molecular Biology;2024-09-02

2. Effectiveness and Safety of Retreatment with¹⁷⁷Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States;Journal of Nuclear Medicine;2024-03-21

3. Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy;EJNMMI Research;2024-02-06

4. Selection and Use of Antioxidants-radioprotectors in the Composition of Therapeutic Radiopharmaceuticals (Review);Drug development & registration;2023-09-26

5. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements;Radiology: Imaging Cancer;2023-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3